Sarcoma

Revised: November 6, 2026

Note: Click on a trial title for more information.

Key:

  • Open
    • VICCSAR2062

      Neoadjuvant Hypofractionated XRT in STS

      • Key Eligibility:
        1. Soft tissue sarcoma of extremity, pelvis, chest wall or trunk/abdominal wall (non-retroperitoneal location)
        2. Age >= 18 years
        3. ECOG 0-2
        4. No prior history of radiation to area to be irradiated
        5. No plans for neoadjuvant chemotherapy
        6. Localized (non-metastatic) disease
        7. Visits: Enrollment, once during treatment, once after completion of radiation, every 3-6 mos after surgery